Inovio Pharmaceuticals Inc (INO)

[cadillac107]

I understand your point, but the fact that Roch partnered with Inovio on prostate cancer products back in 2013, has little or no bearing whether Roche has any interest in getting involved with Zika pharmaceutical development today. My point is that you cannot compare apples and oranges together, and unfortunately, the partnership you cite, will not necessarily stop others drug developers and manufacturers from now entering the competition for the development of the world's first zika drug.